CROI 2015: Advances in antiretroviral therapy

Medicine and Dentistry

• Antiretroviral Therapy 100%
• Human Immunodeficiency Virus 80%
• Woman 80%
• Drug 40%
• Chemotherapeutic Agent 40%
• Disparity 20%
• Isoniazid 20%
• Monotherapy 20%
• Prophylaxis 20%
• Life Expectancy 20%
• Opportunistic Infection 20%
• Retrovirus Infection 20%
• Health Care Cost 20%
• Zidovudine 20%
• HIV Test 20%
• Maturation 20%
• Tenofovir Alafenamide 20%

Nursing and Health Professions

• Antiretroviral Therapy 100%
• Drug 40%
• Child 40%
• Cost Effectiveness Analysis 20%
• World Health Organization 20%
• Monotherapy 20%
• Practice Guideline 20%
• Prophylaxis 20%
• HIV Test 20%
• Zidovudine 20%
• Life Expectancy 20%
• Isoniazid 20%
• Calculation 20%
• Retrovirus Infection 20%
• Opportunistic Infection 20%
• Tenofovir Alafenamide 20%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 80%
• Drug 40%
• Monotherapy 20%
• Isoniazid 20%
• Retrovirus Infection 20%
• Opportunistic Infection 20%
• Zidovudine 20%
• Life Expectancy 20%
• Tenofovir Alafenamide 20%